NON SMALL CELL LUNG CARCINOMA NSCLC
Clinical trials for NON SMALL CELL LUNG CARCINOMA NSCLC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CARCINOMA NSCLC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CARCINOMA NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lung cancer drug aims to outperform current standard
Disease control Recruiting nowThis study tests a new drug called SCTB14 against the standard drug pembrolizumab for people with advanced non-small cell lung cancer that has not been treated yet. About 246 adults with a specific tumor marker (TPS ≥10%) will receive either SCTB14 or pembrolizumab to see which o…
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:12 UTC
-
Lung cancer study questions if lower chemo doses harm older patients
Knowledge-focused Recruiting nowThis study looks at whether giving older lung cancer patients a lower dose of chemotherapy affects how long they live. Researchers will compare survival between patients who got standard doses and those who got reduced doses. The goal is to understand if dose reductions are safe …
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Sponsor: University of Malaya • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC